Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Pasternak

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
ACS Medicinal Chemistry Letters|March 19, 2021
Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 InhibitorsDerun Li, Yongqi Deng, Abdelghani Achab, et al.
Journal of Medicinal Chemistry|December 8, 2022
Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical CandidatesMihirbaran Mandal, Li Xiao, Weidong Pan, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonistsShuwen He, Peter H Dobbelaar, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 DiabetesShrenik K Shah, Shuwen He, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 DiabetesShuwen He, Zhixiong Ye, Quang Truong, et al.
Journal of Medicinal Chemistry|February 22, 2024
Structure Guided Discovery of Novel Pan Metallo-β-Lactamase Inhibitors with Improved Gram-Negative Bacterial Cell PenetrationShuzhi Dong, Zhiqiang Zhao, Haiqun Tang, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
ACS Medicinal Chemistry Letters|March 19, 2021
Carbamate and <i>N</i>-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 InhibitorsDerun Li, Yongqi Deng, Abdelghani Achab, et al.
Journal of Medicinal Chemistry|December 8, 2022
Rapid Evolution of a Fragment-like Molecule to Pan-Metallo-Beta-Lactamase Inhibitors: Initial Leads toward Clinical CandidatesMihirbaran Mandal, Li Xiao, Weidong Pan, et al.
Bioorganic & Medicinal Chemistry Letters|February 23, 2016
SAR exploration at the C-3 position of tetrahydro-β-carboline sstr3 antagonistsShuwen He, Peter H Dobbelaar, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters|May 26, 2015
Discovery of MK-1421, a Potent, Selective sstr3 Antagonist, as a Development Candidate for Type 2 DiabetesShrenik K Shah, Shuwen He, Liangqin Guo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 DiabetesShuwen He, Zhixiong Ye, Quang Truong, et al.
Journal of Medicinal Chemistry|February 22, 2024
Structure Guided Discovery of Novel Pan Metallo-β-Lactamase Inhibitors with Improved Gram-Negative Bacterial Cell PenetrationShuzhi Dong, Zhiqiang Zhao, Haiqun Tang, et al.
Pageof 5